Injectables

Oral (tablets)

Libido

Peptides

Injection Ampoules

Injection Vials

Tablets

Orals

Weight loss, fat burning

Concentração

Concentración

Concentration

Concentrazione

Konzentration

Volume

Volumen

PEN Semaglutide 5 mg Hilma Biocare
PEN Semaglutide 5 mg Hilma Biocare is a modern pharmaceutical product based on semaglutide, the active ingredient also used in Ozempic. It belongs to the class of GLP-1 receptor agonists (glucagon-like peptide-1) and is designed for the treatment of type 2 diabetes, weight management, and prevention of metabolic disorders.

Mechanism of Action
Semaglutide is an analogue of the natural GLP-1 hormone that regulates glucose metabolism. It stimulates insulin secretion in response to elevated blood glucose levels, reduces excessive glucagon production, and slows gastric emptying. This leads to reduced appetite, better control of food intake, and stable blood sugar levels, supporting gradual and sustainable weight loss.

Key Benefits
Effective appetite control by reducing hunger and cravings. Stabilization of blood glucose levels in patients with type 2 diabetes. Improvement of insulin sensitivity and overall glucose metabolism. Support for gradual and long-term weight loss. Proven reduction in cardiovascular risk based on clinical studies of Ozempic. Convenient pen-injector format with pre-attached sterile needles for safe and easy administration.

Indications
Recommended for individuals with obesity (BMI ≥ 30) and for overweight patients (BMI ≥ 27) who have related conditions such as type 2 diabetes, hypertension, dyslipidemia, or sleep apnea. It may also be used by individuals seeking effective weight control and improved metabolic health.

Clinical Effectiveness
Clinical studies have shown that patients using semaglutide achieve an average weight loss of 5–15% with long-term use. Results are enhanced when combined with proper nutrition and physical activity.

Dosage and Administration
Treatment typically begins with a low dose of 0.25 mg once weekly to minimize side effects. The dosage is gradually increased to reach a standard therapeutic level of up to 2.4 mg per week. The medication is administered subcutaneously into the abdomen, thigh, or upper arm. The minimum recommended treatment duration is 16 weeks, with longer use providing more significant results.

Possible Side Effects
Common side effects include nausea, vomiting, diarrhea or constipation, headache, dizziness, and temporary fatigue. In rare cases, hypoglycemia may occur, especially when combined with other antidiabetic medications. Most side effects appear at the beginning of treatment and decrease as the body adapts.

Safety and Storage
The product is manufactured according to international quality standards and undergoes strict sterility and authenticity control. It should be stored in a refrigerator at +2 to +8 °C and must not be frozen. The pen can be kept at room temperature for up to 21 days if needed. Keep in original packaging and out of reach of children.

Achetez Semaglutide 5 mg Pen Hilma Biocare en ligne. GLP-1 efficace pour la perte de poids, le contrôle de l’appétit, l’équilibre glycémique et la santé métabolique.

Acheter Semaglutide 5 mg Pen | Hilma Biocare

PEN Semaglutide 5mg